CVSA(CVSA)
CVSA
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $2.07B | $2.24B | $2.44B |
| Low | $2.06B | $2.21B | $2.43B |
| High | $2.08B | $2.26B | $2.45B |
| EBITDA Avg | $461M | $498M | $543M |
| Low | $459M | $491M | $541M |
| High | $463M | $504M | $545M |
| EBIT Avg | $305M | $330M | $359M |
| Low | $304M | $325M | $358M |
| High | $306M | $333M | $361M |
| Net Income Avg | $316M | $354M | $397M |
| Low | $311M | $348M | $395M |
| High | $321M | $361M | $399M |
| EPS Avg | $8.89 | $9.91 | $11.12 |
| Low | $8.71 | $9.74 | $11.07 |
| High | $8.99 | $10.10 | $11.17 |
| Analysts (Rev / EPS) | 3 / 2 | 3 / 2 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 |
|---|---|---|---|---|
| Revenue Avg | $492M | $536M | $517M | $520M |
| Low | $489M | $531M | $515M | $517M |
| High | $496M | $544M | $522M | $524M |
| EBITDA Avg | $109M | $119M | $115M | $116M |
| Low | $109M | $118M | $115M | $115M |
| High | $110M | $121M | $116M | $117M |
| EBIT Avg | $72M | $79M | $76M | $77M |
| Low | $72M | $78M | $76M | $76M |
| High | $73M | $80M | $77M | $77M |
| Net Income Avg | $62M | $90M | $77M | $75M |
| Low | $62M | $84M | $76M | $74M |
| High | $63M | $95M | $78M | $75M |
| EPS Avg | $1.79 | $2.60 | $2.21 | $2.15 |
| Low | $1.78 | $2.43 | $2.20 | $2.13 |
| High | $1.81 | $2.73 | $2.24 | $2.17 |
| Analysts (Rev / EPS) | 2 / 2 | 3 / 4 | 1 / 1 | 1 / 1 |